These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36400591)

  • 1. Analysis of Risk Factors for a Low Immune Response to Messenger RNA COVID-19 Vaccine in Kidney Transplant Recipients and Differences Between Second and Third Dose.
    Panarese A; Canossi A; Fabiani R; Lupi D; Maccarone D; Pace P; Parzanese I; Martinez V; Lancione L; Savino V; Cacchioni C; Cervelli C; Papola F; Pisani F
    Transplant Proc; 2022 Dec; 54(10):2646-2651. PubMed ID: 36400591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral Response After SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Role of Immunosuppression Therapy.
    López V; Polo C; Schuldt R; Vázquez T; Gutiérrez-Vílchez E; Moliz C; Hernández D
    Transplant Proc; 2022 Nov; 54(9):2454-2456. PubMed ID: 36273957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
    Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
    JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.
    Rozen-Zvi B; Yahav D; Agur T; Zingerman B; Ben-Zvi H; Atamna A; Tau N; Mashraki T; Nesher E; Rahamimov R
    Clin Microbiol Infect; 2021 Aug; 27(8):1173.e1-1173.e4. PubMed ID: 33957273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of two doses of SARS-CoV-2 mRNA vaccine in kidney transplant recipients with low-dose rituximab.
    Takai S; Nishida H; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Kato T; Morikane K; Tsuchiya N
    Int J Urol; 2022 Nov; 29(11):1279-1286. PubMed ID: 35863901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
    Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody acquisition after second and third SARS-CoV-2 vaccinations in Japanese kidney transplant patients: a prospective study.
    Deguchi H; Sakamoto A; Nakamura N; Okabe Y; Miura Y; Iida T; Yoshimura M; Haga N; Nabeshima S; Masutani K
    Clin Exp Nephrol; 2023 Jun; 27(6):574-582. PubMed ID: 36914824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients.
    Harberts A; Schaub GM; Ruether DF; Duengelhoef PM; Brehm TT; Karsten H; Fathi A; Jahnke-Triankowski J; Fischer L; Addo MM; Haag F; Luetgehetmann M; Lohse AW; Schulze Zur Wiesch J; Sterneck M
    Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2558-2566.e5. PubMed ID: 35850415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients.
    Hoffman TW; Meek B; Rijkers GT; van Kessel DA
    Transpl Immunol; 2022 Jun; 72():101599. PubMed ID: 35390480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic response to SARS-CoV-2 mRNA vaccination in pediatric kidney transplant recipients.
    Kermond RF; Ozimek-Kulik JE; Kim S; Alexander SI; Hahn D; Kesson A; Wood N; McCarthy HJ; Durkan AM
    Pediatr Nephrol; 2023 Mar; 38(3):859-866. PubMed ID: 35833990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective Study.
    Yahav D; Rahamimov R; Mashraki T; Ben-Dor N; Steinmetz T; Agur T; Zingerman B; Herman-Edelstein M; Lichtenberg S; Ben-Zvi H; Bar-Haim E; Cohen H; Rotem S; Elia U; Margalit I; Zvi BR
    Transpl Int; 2022; 35():10204. PubMed ID: 35529596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of frailty syndrome on humoral response to SARS-CoV-2 mRNA vaccines in older kidney transplant recipients.
    Schmalz M; Vankova H; Rajnochova-Bloudickova S; Hruba P; Fialova M; Gurka J; Magicova M; Striz I; Zahradka I; Viklicky O
    Int Urol Nephrol; 2023 Nov; 55(11):2959-2965. PubMed ID: 37027078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients.
    Crane C; Phebus E; Ingulli E
    Pediatr Nephrol; 2022 Feb; 37(2):449-453. PubMed ID: 34522992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients.
    Grupper A; Rabinowich L; Ben-Yehoyada M; Katchman E; Baruch R; Freund T; Hagin D; Shlomo SB; Schwartz D; Schwartz IF; Shashar M; Bassat OK; Halperin T; Turner D; Saiag E; Goykhman Y; Shibolet O; Levy S; Houri I; Katchman H
    Transplant Proc; 2022; 54(6):1439-1445. PubMed ID: 35346486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The type of SARS-CoV-2 vaccine influences serological response in kidney transplant recipients.
    Correia AL; Leal R; Pimenta AC; Fernandes M; Guedes Marques M; Rodrigues L; Santos L; Romãozinho C; Sá H; Pratas J; Araújo L; Figueiredo A; Alves R
    Clin Transplant; 2022 Apr; 36(4):e14585. PubMed ID: 34997797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral and Cellular Response of Transplant Recipients to a Third Dose of mRNA SARS-CoV-2 Vaccine: A Systematic Review and Meta-analysis.
    Bailey AJM; Maganti HB; Cheng W; Shorr R; Arianne Buchan C; Allan DS
    Transplantation; 2023 Jan; 107(1):204-215. PubMed ID: 36398334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Correlation Between Responders and Non-Responders to the Second Coronavirus Disease Vaccination In Kidney Transplant Recipients: A Retrospective Single-Center Cohort Study.
    Matsunami M; Suzuki T; Sugihara S; Toishi T; Nagaoka K; Fukuda J; Ohara M; Takanashi Y; Ochi A; Yashima J; Kuji H; Matsue K
    Transplant Proc; 2022; 54(6):1483-1488. PubMed ID: 35868872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral response after a third and fourth dose of mRNA-based SARS-CoV-2 vaccine in previously seronegative kidney transplant recipients.
    Brandstetter C; Haller MC; Berger JM; Kerschner H; Apfalter P; Cejka D
    Wien Klin Wochenschr; 2022 Dec; 134(23-24):815-821. PubMed ID: 36326920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torque teno virus viral load predicts SARS-CoV-2 vaccine response in kidney transplant recipients.
    Solis M; Benotmane I; Gallais F; Caillard S; Fafi-Kremer S
    J Med Virol; 2023 Jul; 95(7):e28936. PubMed ID: 37404001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.
    Lee ARYB; Wong SY; Chai LYA; Lee SC; Lee MX; Muthiah MD; Tay SH; Teo CB; Tan BKJ; Chan YH; Sundar R; Soon YY
    BMJ; 2022 Mar; 376():e068632. PubMed ID: 35236664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.